Gå til innhold
  • Send

  • Kategori

  • Sorter etter

  • Antall per side

Fant 9758 publikasjoner. Viser side 131 av 391:

Publikasjon  
År  
Kategori

Exposure assessment with the urban exposure management tool - case study Oslo.

Lützenkirchen, S.; Laupsa, H.; Fløisand, I.; Bøhler, T.

2006

Exposure maps for two megacities within the MEGAPOLI project.

Soares, J.; Karppinen, A.; Kukkonen, J.; Denby, B.; Finard, S.; Cassiani, M.; Radice, P.

2011

Exposure of children and adults to particulate matter in urban areas - model calculations. NILU PP

Fløisand, I.; Mc Innes, H.; Broday, D.; Lützenkirchen, S.; Holländer, W.; Bartonova, A.; Jablonska, H.T.B.

2007

Exposure of children to particulate matter in urban areas - model calculations.

Fløisand, I.; Mc Innes, H.; Broday, D.; Lützenkirchen, S.; Holländer, W.; Bartonova, A.

2006

Exposure risks from pollutants in domestic environments: The urban exposure project.

Coulson, G.; Bartonova, A.; Bøhler, T.; Broday, D.M.; Colbeck, I.; Fløisand, I.; Fudala, J.; Hollander, W.; Housiadas, C.; Lazaridis, M.; Smolik, J.

2005

Exposure scenario approach to environmental health problems: two case studies. NILU F

Bartonova, A.; Liu, H.Y.; Loh, M.; ENVIRISK team.

2011

Exposure to multiple environmental agents and their effect.

Koppe, J.; Bartonova, A.; Bolte, G.; Bistrup, M.L.; Busby, C.; Butter, M.; Dorfman, P.; Fucic, A.; Gee, D.; Van Den Hazel, P.; Howard, V.; Kohlhuber, M.; Leijs, M.; Lundqvist, C.; Moshammer, H.; Naginiene, R.; Nicolopoulou-Stamati, P.; G.; Wallis, M.; Zuurbier, M.

2006

Exposure to oxychlordane is associated with shorter telomeres in arctic breeding kittiwakes.

Blevin, P.; Angelier, F.; Tartu, S.; Ruault, S.; Bustamante, P.; Herzke, D.; Moe, B.; Bech, C.; Gabrielsen, G.W.; Bustnes, J.O.; Chastel, O.

2016

Exposure to PFAS is associated with telomere length dynamics and demographic responses of an arctic top predator

Sebastiano, Manrico; Angelier, Frédéric; Blévin, Pierre; Ribout, Cécile; Sagerup, Kjetil; Descamps, Sebastien; Herzke, Dorte; Moe, Børge; Barbarud, Christophe; Bustnes, Jan Ove; Gabrielsen, Geir W.; Chastel, Olivier

2020

Expression of DNA repair genes in arctic char (Salvelinus alpinus) from Bjørnøya in the Norwegian Arctic

Inderberg, Helene; Neerland, Eirik D.; Mcpartland, Molly; Sparstad, Torfinn; Bytingsvik, Jenny; Nikiforov, Vladimir; Evenset, Anita; Krøkje, Åse

Academic Press

2021

Extensive release of methane from Arctic seabed west of Svalbard during summer 2014 does not influence the atmosphere.

Myhre, C.L.; Ferré, B.; Platt, S.M.; Silyakova, A.; Hermansen, O.; Allen, G.; Pisso, I.; Schmidbauer, N.; Stohl, A.; Pitt, J.; Jansson, P.; Greinert, J.; Percival, C.; Fjaeraa, A.M.; O'Shea, S.J.; Gallagher, M.; Le Breton, M.; Bower, K.N.; Bauguitte, S.J.B.; Dalsøren, S.; Vadakkepuliyambatta, S.; Fisher, R.E.; Nisbet, E.G.; Lowry, D.; Myhre, G.; Pyle, J.A.; Cain, M.; Mienert, J.

2016

Extracellular Vesicles as Next-Generation Diagnostics and Advanced Therapy Medicinal Products

Stawarska, Agnieszka; Bamburowicz-Klimkows, Magdalena; Rundén-Pran, Elise; Dusinska, Maria; Cimpan, Mihaela Roxana; Rios Mondragon, Ivan; Grudzinski, Ireneusz P.

Extracellular vesicles (EVs) hold great promise for clinical application as new diagnostic and therapeutic modalities. This paper describes major GMP-based upstream and downstream manufacturing processes for EV large-scale production, also focusing on post-processing technologies such as surface bioengineering and uploading studies to yield novel EV-based diagnostics and advanced therapy medicinal products. This paper also focuses on the quality, safety, and efficacy issues of the bioengineered EV drug candidates before first-in-human studies. Because clinical trials involving extracellular vesicles are on the global rise, this paper encompasses different clinical studies registered on clinical-trial register platforms, with varying levels of advancement, highlighting the growing interest in EV-related clinical programs. Navigating the regulatory affairs of EVs poses real challenges, and obtaining marketing authorization for EV-based medicines remains complex due to the lack of specific regulatory guidelines for such novel products. This paper discusses the state-of-the-art regulatory knowledge to date on EV-based diagnostics and medicinal products, highlighting further research and global regulatory needs for the safe and reliable implementation of bioengineered EVs as diagnostic and therapeutic tools in clinical settings. Post-marketing pharmacovigilance for EV-based medicinal products is also presented, mainly addressing such topics as risk assessment and risk management.

MDPI

2024

Extraordinary halocarbon emissions initiated by the 2011 Tohoku earthquake.

Saito, T.; Fang, X.; Stohl, A.; Yokouchi, Y.; Zeng, J.; Fukuyama, Y.; Mukai, H.

2015

Extreme climate of the global troposphere and stratosphere in the 1940-42 related to El Nino.

Brönnimann, S.; Luterbacher, J.; Staehelin, J.; Svendby, T. M.; Hansen, G.; Svenøe, T.

2004

Publikasjon
År
Kategori